Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Jazz Pharmaceuticals plc Director's Dealing 2016

Feb 12, 2016

30751_dirs_2016-02-12_8ec45e94-cf0e-4fa9-91aa-6876c0a5226b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2016-02-10

Reporting Person: ENRIGHT PATRICK G (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-02-10 Ordinary Shares S 294 $114.4267 Disposed 225187 Indirect
2016-02-10 Ordinary Shares S 1698 $116.1978 Disposed 223489 Indirect
2016-02-10 Ordinary Shares S 2594 $117.4604 Disposed 220895 Indirect
2016-02-10 Ordinary Shares S 3159 $118.3959 Disposed 217736 Indirect
2016-02-10 Ordinary Shares S 1666 $119.5471 Disposed 216070 Indirect
2016-02-10 Ordinary Shares S 393 $120.3245 Disposed 215677 Indirect
2016-02-10 Ordinary Shares S 6 $114.4267 Disposed 4513 Indirect
2016-02-10 Ordinary Shares S 34 $116.1915 Disposed 4479 Indirect
2016-02-10 Ordinary Shares S 52 $117.4574 Disposed 4427 Indirect
2016-02-10 Ordinary Shares S 63 $118.3934 Disposed 4364 Indirect
2016-02-10 Ordinary Shares S 34 $119.5471 Disposed 4330 Indirect
2016-02-10 Ordinary Shares S 7 $120.3064 Disposed 4323 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Ordinary Shares 1310 Direct

Footnotes

F1: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $114.04 to $114.64. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

F2: The Reporting Person is a managing member of Longitude Capital Partners, LLC, the general partner of each of Longitude Venture Partners, L.P. and Longitude Capital Associates, L.P. The Reporting Person disclaims beneficial ownership of the securities of the Issuer held by Longitude Venture Partners, L.P. and Longitude Capital Associates, L.P. except to the extent of his pecuniary interest therein.

F3: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $115.71 to $116.60. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

F4: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $116.90 to $117.81. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

F5: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $117.96 to $118.7703. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

F6: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $119.05 to $120.0424. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

F7: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $120.13 to $120.4485. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

F8: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $114.04 to $114.64. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

F9: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $115.71 to $116.56. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

F10: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $116.90 to $117.81. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

F11: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $117.96 to $118.7703. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

F12: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $119.05 to $120.0424. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

F13: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $120.13 to $120.4485. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.